The blockbuster weight loss drug sold as Ozempic and Wegovy will soon go generic in countries that are home to 40 percent of the worlds population, significantly lowering the price of a costly medicine that had been largely unaffordable to nearly all but the wealthiest people
Your provider will evaluate which semaglutide option best aligns with your health specifics, insurance stipulations, and personal preferences, ensuring you receive optimal care suited to your needs
It becomes a much weaker tool for patients with a BMI over 35 or obesity-related conditions like Type 2 diabetes, hypertension, or sleep apnea
People with pre-existing arrhythmias, heart failure, or ischaemic heart disease may face heightened cardiac risk due to retatrutide's heart rate-elevating effects and glucagon receptor activity
Anecdotal evidence suggests this could express itself by stretching doses, delaying injections to manage OOP costs
Rotate Wegovy injection sites to avoid discomfort and bruising
